HomeTrading IdeasAltcoin Rotation Gains Steam...

Altcoin Rotation Gains Steam as Bitcoin and Ethereum Take a Backseat

Despite increasing trade tensions and tariff worries, crypto continues to hold up. More than that, the group is actually performing pretty well.

is leaning on a potential breakout, but it’s not doing the heavy lifting right now. To some extent, neither is .

Instead, it’s more broad.

Stellar, , Aave, and others are starting to gain momentum — and we’re still keeping a close eye on to see if it can complete its breakout attempt.

There’s no guarantee crypto will continue to hold up. But if it can and if the rally broadens out? Then it could be a solid second half for this asset class.

For investors who can’t trade or aren’t comfortable trading cryptocurrencies outright, they can consider ETFs for BTC and ETH. On the BTC front, IBIT remains the largest ETF by assets, and it also supports options trading.

The Setup — JPMorgan

Last week, JPMorgan Chase & Co (NYSE:) shares hit a record high. Over the next two days though, it stumbled almost 5%. The pullback landed it right at its prior all-time high and the rising 21-day moving average.

For a stock that’s rallied almost 50% off its April lows, a little profit taking was due — particularly as the overall financial sector took a rest yesterday, dipping about 1%.

Now though, bulls want to know if the stock will find support and bounce from here.Source: eToro ProCharts, courtesy of TradingView.

Active investors might consider a dip-buy in this name if they believe it can rebound from the recent lows. For some, that may make call options an attractive play (more on that below).

JPMorgan reports earnings next Tuesday. While that may give investors a little optimism ahead of the event, it’s key to remember that the outcome is unknown. Shares could fly higher on good results or sink on a disappointing report.

For now, bulls are hoping support comes into play and JPM can bounce. But if it breaks below $280, more selling pressure could ensue ahead of earnings.

Options

One downside to JPM is its share price. Because the stock price is so high, the options prices are incredibly high, too. This can make it difficult for investors to approach these companies with options.

In that case, many traders may opt to just trade a few shares of the common stock — and that’s fine. However, one alternative is spreads.

Call spreads and put spreads allow traders to take options trades with a much lower premium than buying the calls outright. In these cases, the maximum risk is the premium paid.

What Wall Street Is Watching

DAL

Delta Air Lines (NYSE:) will report earnings on Thursday before the open. Despite some lumpiness in travel trends (as Delta noted last quarter), the stock has done great. Shares are up ~41% since it last reported earnings. Can it continue higher?

UBER

Did someone hail a rally? Uber (NYSE:) stock has been on fire, notching another record high on Tuesday. Bulls are hoping for a third straight week of gains, as the stock is already up more than 16% in that stretch. For the year, shares are up more than 60%.

Most Popular

More from Author

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three...

Read Now

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer as Trump announced yet another delay in tariff deadlines – From the approaching July 9th to August 1st, apparently the final warning. The session began with the leading to the upside, followed by general mean-reversion all...

Gilead’s Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million – Gilead Sciences (NASDAQ:GILD)

Gilead Sciences, Inc. GILD on Wednesday announced a strategic partnership agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to supply lenacapavir — Gilead’s twice-yearly injectable HIV-1 capsid inhibitor — for the prevention of HIV as pre-exposure prophylaxis (PrEP).Through the agreement, Gilead will supply enough...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three years as investors hope for new steps to fight deflation and boost the economy. Meanwhile, dropped in London after President Donald Trump issued a new tariff warning.Asian Market WrapThe Shanghai Stock Exchange Composite Index rose...

FDA Approves New Dosing Schedule For Eli Lilly’s Kisunla In Alzheimer’s Treatment – Eli Lilly (NYSE:LLY)

The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s LLY Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The FDA approved the drug in July 2024.In the TRAILBLAZER-ALZ 6...

H2 2025: Room for Optimism, Risk for Complacency

Reasons To Be Fearful, Reasons To Be Cheerful It was an eventful first half of the year, to say the least... In January, the rise of DeepSeek was a wake-up call for the world, demonstrating that China is a major competitor to the US in AI and technology. The...

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug – Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA)

Merck & Co. Inc. MRK agreed on Wednesday to acquire Verona Pharma plc VRNA for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ADS represents eight ordinary shares of Verona Pharma.Through the acquisition of this respiratory disease-focused company, Merck...

The Energy Report: Demand Exceeding Supply

It’s the oldest story in the book. Prices go up when demand exceeds supply, not only in oil and products but in wholesale power, driving up electricity costs. The Energy Information Administration (EIA) in its Short-Term Energy Outlook confirmed that we have a global supply deficit. Not only...

DAX Pushes Higher as EU Edges Closer to Tariff Deal With US

rises as investors await trade news from Trump. shows resilience despite a rise in inventories and uncertainty over trade tariffs. The DAX, along with European indices, is inching higher on Wednesday, supported by defence stocks as investors wait for news on a trade deal with the...

Oil Prices Near 2-Week Highs on OPEC+ Output and US Tariffs

climbed Tuesday, hovering near two-week highs as markets absorbed the impact of a larger-than-expected OPEC+ production increase and ongoing uncertainty around US trade policy. As of mid-afternoon, was up 89 cents at $70.47 per barrel, while US West Texas Intermediate rose 80 cents to $68.73. Both...

Oil: Can the Market Absorb OPEC+ Output Hikes?

OPEC+ surprised markets by announcing a larger-than-expected August output hike of 548,000 bpd. Analysts say actual supply increases remain limited due to ongoing compensation cuts. Strong summer demand, especially from Asia, is expected to absorb the added barrels, but demand could falter this autumn. OPEC+ never fails to surprise speculators...

US Dollar Fights an Uphill Battle Amidst Mounting Tariff Pressure

More Trump letters to be sent, with copper, chips, and pharma next on the tariff list Dollar struggles to hold recent gains, except versus the yen US equities are on the back foot, underperforming their European counterparts RBNZ stands pat; Antipodeans post small gains against the greenback Dollar Is Swimming UpstreamThe...

Big Oil Faces Weaker Quarter, but OPEC+ Output Move Signals Underlying Strength

Shell and Exxon warned of weaker Q2 earnings due to lower oil and gas prices, with Exxon expecting a $1.5 billion hit. Despite bearish forecasts, OPEC+ raised output and prices rose, suggesting demand remains stronger than expected—challenging the EV-driven demand collapse narrative. Analysts view the dip as cyclical, not...